Entity
  • Arvinas

    Created in 2013
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    3,156 22,923
  • Activities

  • Technologies

  • Entity types

  • Location

    395 Winchester Ave, New Haven, CT 06511, USA

    New Haven

    United States of America

  • Employees

    Scale: 201-500

    Estimated: 444

  • Engaged corporates

    4
    0 2
  • Added in Motherbase

    1 year, 7 months ago
Description
  • Value proposition

    Leading the way in targeted protein degradation therapeutics

    Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma.

    Based in the biotech hub of New Haven, CT, Arvinas is driven by an industry-leading team dedicated to improving the lives of people living with serious diseases. For more information, visit www.arvinas.com.

    Community Guidelines: http://bit.ly/ArvinasCG

  • Protein Degradation with PROTAC Protein Degraders | Arvinas

    Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.

  • https://www.arvinas.com/
Corporate interactions BETA
Corporate TypeTweets Articles
J.P. Morgan J.P. Morgan
Bank
Other

5 Jan 2024


Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Other

5 Nov 2024


Amgen
Amgen
Biotechnology, Biotechnology Research
Amgen
Biotechnology, Biotechnology Research
Other

5 Mar 2021


Bayer
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Other

8 Jan 2020


Similar entities
Loading...
Loading...
Social network dynamics